Cerella™ employs a cutting-edge deep learning technique to address challenges in drug discovery data, enhancing efficiency and reducing costs. By identifying high-quality compounds with confidence, Cerella uncovers hidden opportunities arising from missing, uncertain, or inaccurate data and prioritizes the most valuable experiments. From early hit analysis to preclinical candidate selection, Cerella delivers exceptional results, tailored for enterprise deployment and seamless integration with experimentalists' workflows.